Cardiology editorials ‘rife’ with financial conflicts

A study of commentaries in leading journals finds the authors frequently have ties with industry and often these are not disclosed   
Reuters Health
money in medicine

More than half of medical journal editorials commenting on randomised controlled trials of invasive cardiovascular interventions have a link with the trial sponsor, a study shows.

The analysis of 82 commentaries on 79 trials published during a period of more than six years found 46 (56%) had at least one author with a declared financial conflict of interest.